|
Investment in Phusion Laboratories LLC (Details Textual) (USD $)
|
1 Months Ended | 9 Months Ended | |||||
|---|---|---|---|---|---|---|---|
|
Sep. 30, 2012
|
Dec. 31, 2011
|
Sep. 30, 2011
|
Dec. 31, 2010
|
Sep. 30, 2011
PSI Parent [Member]
|
Sep. 30, 2012
PSI Parent [Member]
|
Sep. 30, 2012
Corporate Joint Venture [Member]
|
|
| Stock Issued During Period, Shares, New Issues | 1,440,000 | ||||||
| Stock Issued During Period, Value, New Issues | $ 2,600,000 | ||||||
| Payments to Acquire Interest in Joint Venture | 1,000,000 | ||||||
| Treasury stock purchase (in shares) | 690,000 | ||||||
| Maximum Amount Committed Towards Contributions In Joint Venture | 2,000,000 | ||||||
| Cash and Cash Equivalents, At Carrying Value | 1,815,000 | 5,541,000 | 4,616,000 | 8,232,000 | 388,000 | ||
| Acquisition of product license | 3,600,000 | ||||||
| Finite-Lived Intangible Assets, Useful Life (in years) | 10 years | ||||||
| Common Stock Number Of Share Transferred To Thired Party | 750,000 | ||||||
| Equity Redemption ,Number Of Share, Redeem | 690,000 | ||||||
| Equity Redemption Price Per Share | $ 0.65 | ||||||
| Equity Redemption Value | $ 448,500 | ||||||
| X | ||||||||||
|
- Definition
No authoritative reference available. No definition available.
|
| X | ||||||||||
|
- Definition
The number of share that are redeemed during the period. No definition available.
|
| X | ||||||||||
|
- Definition
The amount to be paid per share equity by entity upon redemption of securities during the period. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate amount to be paid by the entity upon redemption of the equity share during the period. No definition available.
|
| X | ||||||||||
|
- Definition
Maximum amount committed towards contributions in joint venture No definition available.
|
| X | ||||||||||
|
- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
|
- Definition
The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of shares that have been repurchased during the period and are being held in treasury. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|